World News: 06:32 GMT Friday 9th November 2018. [DBV Technologies S.A. via Globe Newswire via SPi World News]
DBV Technologies Euronext DBV - ISIN FR0010417345 - Nasdaq Stock Market: DBVT a clinical-stage biopharmaceutical company today announced that additional analyses from clinical trials of Viaskin Peanut will be presented at the 2018 American Col lege of...
Globe Newswire: 06:32 GMT Friday 9th November 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.